BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34110904)

  • 1. Advances in Revascularization for Peripheral Artery Disease: Revascularization in PAD.
    Beckman JA; Schneider PA; Conte MS
    Circ Res; 2021 Jun; 128(12):1885-1912. PubMed ID: 34110904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endovascular intervention for peripheral artery disease.
    Thukkani AK; Kinlay S
    Circ Res; 2015 Apr; 116(9):1599-613. PubMed ID: 25908731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and perioperative outcomes of patients with human immunodeficiency virus (HIV) undergoing lower extremity revascularization.
    Kim TI; Brahmandam A; Sarac TP; Orion KC
    Vasc Med; 2020 Dec; 25(6):527-533. PubMed ID: 33019909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication.
    ; Conte MS; Pomposelli FB; Clair DG; Geraghty PJ; McKinsey JF; Mills JL; Moneta GL; Murad MH; Powell RJ; Reed AB; Schanzer A; Sidawy AN;
    J Vasc Surg; 2015 Mar; 61(3 Suppl):2S-41S. PubMed ID: 25638515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-hospital versus postdischarge major adverse events within 30 days following lower extremity revascularization.
    Liang P; Li C; O'Donnell TFX; Lo RC; Soden PA; Swerdlow NJ; Schermerhorn ML
    J Vasc Surg; 2019 Feb; 69(2):482-489. PubMed ID: 30301689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
    Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
    J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of chronic opioid use in patients with peripheral arterial disease undergoing revascularization.
    Velazquez-Ramirez G; Krebs J; Stafford JM; Ur R; Craven TE; Stutsrim AE; Goldman MP; Hurie JB; Edwards MS
    J Vasc Surg; 2022 Jan; 75(1):186-194. PubMed ID: 34478808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical intervention for peripheral arterial disease.
    Vartanian SM; Conte MS
    Circ Res; 2015 Apr; 116(9):1614-28. PubMed ID: 25908732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication.
    Fashandi AZ; Mehaffey JH; Hawkins RB; Kron IL; Upchurch GR; Robinson WP
    J Vasc Surg; 2018 Dec; 68(6):1817-1823. PubMed ID: 30470369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endovascular interventions for peripheral arterial disease].
    Steiner S; Schmidt A
    Inn Med (Heidelb); 2022 Jun; 63(6):584-590. PubMed ID: 35532802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of Bypass as a Revascularization Option for Patients With Chronic Limb-Threatening Ischemia.
    Paraskevas KI; Veith FJ
    Angiology; 2023 Oct; 74(9):809-811. PubMed ID: 36880697
    [No Abstract]   [Full Text] [Related]  

  • 12. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    Almasri J; Adusumalli J; Asi N; Lakis S; Alsawas M; Prokop LJ; Bradbury A; Kolh P; Conte MS; Murad MH
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1S):S110-S119. PubMed ID: 31221539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary Management of Critical Limb Ischemia.
    Thompson JR; Henke PK
    Adv Surg; 2018 Sep; 52(1):257-274. PubMed ID: 30098617
    [No Abstract]   [Full Text] [Related]  

  • 14. A systematic review and meta-analysis of risk factors for and incidence of 30-day readmission after revascularization for peripheral artery disease.
    Smith SL; Matthews EO; Moxon JV; Golledge J
    J Vasc Surg; 2019 Sep; 70(3):996-1006.e7. PubMed ID: 31445653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interventional angiology : Endovascular treatment of chronic and acute limb ischemia].
    Steiner S; Schmidt A; Scheinert D
    Internist (Berl); 2019 Feb; 60(2):149-160. PubMed ID: 30683968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical appraisal of surgical revascularization for critical limb ischemia.
    Conte MS
    J Vasc Surg; 2013 Feb; 57(2 Suppl):8S-13S. PubMed ID: 23336860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional variation in patient selection and treatment for lower extremity vascular disease in the Vascular Quality Initiative.
    Soden PA; Zettervall SL; Curran T; Vouyouka AG; Goodney PP; Mills JL; Hallett JW; Schermerhorn ML;
    J Vasc Surg; 2017 Jan; 65(1):108-118. PubMed ID: 27692467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of lower-extremity revascularization.
    Friedell ML; Stark KR; Kujath SW; Carter RR
    Curr Probl Surg; 2014 Jun; 51(6):254-90. PubMed ID: 24863077
    [No Abstract]   [Full Text] [Related]  

  • 19. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supervised exercise therapy and revascularization: Single-center experience of intermittent claudication management.
    Bouwens E; Klaphake S; Weststrate KJ; Teijink JA; Verhagen HJ; Hoeks SE; Rouwet EV
    Vasc Med; 2019 Jun; 24(3):208-215. PubMed ID: 30795714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.